Australia's largest stock trading and investment forum Australia's #1 stock forum

IIQ

0.85%

59.5¢ inoviq ltd

What are we waiting for?, page-21

First 21 Last

Share
Profile

Follow
BAOAS

386 Posts.

77

21/07/21

07:57

Post #: 54646360
Share

Originally posted by Kensington001: ↑

evening all....
Hope you can enlighten me a little. I was reading on the upcoming listing of BCAL (possibly tomorrow) and then as is the way you follow the tentacles out and start reading about other related companies and eventually forget what you are doing in the first place and it's 2am. Then I found this thread - which given then way it starts, with one of your own investors who forgot why he bought the company asking what they do !! Which I thought was gold, I thought it would be a safe place to come ask a few questions.

I know it's a competitive industry the medical field....but first mover in this place and then the best test, would seem to be a winner worldwide. So whilst reading up on BCAL - who has a test for Breast cancer with a 91% sensitivity and 87% accuracy, they actually mention a few competitors in the prospectus. two of these are already commercially available in the US
for example:
Provista Diagnostics in the US (which looks like was recently bought out for $7.5M)
Grail - who produce Galleri
And they also mention BD1 (also mention RHY but I am across them and they arent involved in breast cancer).
And for Breast cancer for BD1 - 100% accuracy and 95% specificity on top of a bunch of other results for diff cancers at similar results
And I am sure there are dozens of others competitors....

So for someone that is pretty green to all of this....I know the accuracy and specificity are important and a good measure....but when I initially saw the BD1 results from earlier in the year I thought, why would any other companies now bother - those results look like they'll almost never be beaten. But still we have companies raising cash and listing, focussing mainly on a single cancer, with results suggested to be less than BD1 has...so I just don't get it. Also don't get, with the amount of money and time you'd be needing to invest now, why we don't have the US commercialised products available in Oz if they were any good.

So much I just don't understand. Would be interested, not in some pumping rah rah rah type response about BD1, but an informed response about the industry - specifically about breast cancer detection, and BD1's place in the race to find a solution

So I know what your company does at a very high level, just struggling to piece together the competition, results from competitors in comparison, pathways to success if anyone is really on the ball with this. Things like - is the BD1 timeline massively behind BCAL, thats why BCAL is still chugging away....

thanks in advance !

Expand

Morning mate, welcome!

With regard to the competition, I guess things like the cost of test, speed of results, ability to produce tests quickly en mass and also just the fact that its such a huge market that there's plenty of revenue to go around.

First in market & best in market are great if you can achieve one, amazing if you can achieve both, but even if you can't do either there is still $$ to be made for other companys.

BD1 Price at posting: $1.80 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

BOE

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

BIO

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

AZL

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

PAM

PAM secures high-grade Chilean copper play in strong territory

IVZ

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

There are more pages in this discussion • 6 more messages in this thread...

First 21 Last

Add IIQ (ASX) to my watchlist

(20min delay)
Last 59.5¢		Change 0.005(0.85%)		Mkt cap ! $65.06M

Open	High	Low	Value	Volume
59.5¢	59.5¢	59.5¢	$3.71K	6.235K

Buyers (Bids)

No.	Vol.	Price($)
1	3765	59.5¢

Sellers (Offers)

Price($)	Vol.	No.
60.0¢	8174	2

View Market Depth

No.	Vol.	Price($)
1	3765	0.595
2	41547	0.585
1	2549	0.580
1	5000	0.575
4	26481	0.565

Price($)	Vol.	No.
0.600	8174	2
0.605	5000	1
0.610	12499	4
0.620	19392	3
0.625	1584	1

Last trade - 11.03am 29/07/2024 (20 minute delay)

IIQ (ASX) Chart

What are we waiting for?, page-21

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

PAM secures high-grade Chilean copper play in strong territory

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

What are we waiting for?, page-21

Top Stories

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

PAM secures high-grade Chilean copper play in strong territory

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News